Identification of Novel Inhibitors of Mycobacterium tuberculosis PknG Using Pharmacophore Based Virtual Screening, Docking, Molecular Dynamics Simulation, and Their Biological Evaluation

PknG is a Ser/thr protein kinase that plays a crucial role in regulatory processes within the mycobacterial cell and signaling cascade of the infected host cell. The essentiality of PknG in mycobacterial virulence by blocking phagosome-lysosome fusion as well as its role in intrinsic antibiotic resistance makes it an attractive drug target. However, only very few compounds have been reported as Mycobacterium tuberculosis PknG (MtPknG) inhibitors so far. Therefore, in an effort to find potential inhibitors against MtPknG, we report here a sequential pharmacophore-based virtual screening workflow, 3-fold docking with different search algorithms, and molecular dynamic simulations for better insight into the predicted binding mode of identified hits. After detailed analysis of the results, six ligands were selected for in vitro analysis. Three of these molecules showed significant inhibitory activity against MtPknG. In addition, inhibitory studies of mycobacterial growth in infected THP-1 macrophages demonstrated considerable growth inhibition of M. bovis BCG induced through compound NRB04248 without any cytotoxic effect against host macrophages. Our results suggest that the compound NRB04248 can be explored for further design and optimization of MtPknG inhibitors.

[1]  Y Av-Gay,et al.  The eukaryotic-like Ser/Thr protein kinases of Mycobacterium tuberculosis. , 2000, Trends in microbiology.

[2]  M. Steinmetz,et al.  Structural basis for the specific inhibition of protein kinase G, a virulence factor of Mycobacterium tuberculosis , 2007, Proceedings of the National Academy of Sciences.

[3]  Namrata Anand,et al.  Synthesis and evaluation of small libraries of triazolylmethoxy chalcones, flavanones and 2-aminopyrimidines as inhibitors of mycobacterial FAS-II and PknG. , 2012, Bioorganic & medicinal chemistry.

[4]  B. Halioua,et al.  La tuberculose en ancienne Égypte , 2007 .

[5]  Moslem Bahadori,et al.  A brief history of tuberculosis in Iran during the 19th and 20th centuries. , 2011, Archives of Iranian medicine.

[6]  Priyanka Gupta,et al.  Identification of novel inhibitors of human Chk1 using pharmacophore-based virtual screening and their evaluation as potential anti-cancer agents , 2014, Journal of Computer-Aided Molecular Design.

[7]  Mohammad Imran Siddiqi,et al.  Integrating molecular docking, CoMFA analysis, and machine-learning classification with virtual screening toward identification of novel scaffolds as Plasmodium falciparum enoyl acyl carrier protein reductase inhibitor , 2014, Medicinal Chemistry Research.

[8]  Liem Nguyen,et al.  The Trojan horse: survival tactics of pathogenic mycobacteria in macrophages. , 2005, Trends in cell biology.

[9]  Ashutosh Kumar,et al.  Virtual screening against Mycobacterium tuberculosis dihydrofolate reductase: suggested workflow for compound prioritization using structure interaction fingerprints. , 2008, Journal of molecular graphics & modelling.

[10]  B Ziskind,et al.  [Tuberculosis in ancient Egypt]. , 2007, Revue des maladies respiratoires.

[11]  I. Wilson,et al.  Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. , 2000, European journal of biochemistry.

[12]  Thomas Lengauer,et al.  A fast flexible docking method using an incremental construction algorithm. , 1996, Journal of molecular biology.

[13]  Osmar Norberto de Souza,et al.  Discovery of New Inhibitors of Mycobacterium tuberculosis InhA Enzyme Using Virtual Screening and a 3D-Pharmacophore-Based Approach , 2013, J. Chem. Inf. Model..

[14]  Liem Nguyen,et al.  Protein Kinase G from Pathogenic Mycobacteria Promotes Survival Within Macrophages , 2004, Science.

[15]  William L. Jorgensen,et al.  Journal of Chemical Information and Modeling , 2005, J. Chem. Inf. Model..

[16]  Mahmoud ElHefnawi,et al.  Multiple virtual screening approaches for finding new Hepatitis c virus RNA-dependent RNA polymerase inhibitors: Structure-based screens and molecular dynamics for the pursue of new poly pharmacological inhibitors , 2012, BMC Bioinformatics.

[17]  Liem Nguyen,et al.  Role of Protein Kinase G in Growth and Glutamine Metabolism of Mycobacterium bovis BCG , 2005, Journal of bacteriology.

[18]  B. Barrell,et al.  Massive gene decay in the leprosy bacillus , 2001, Nature.

[19]  M. Siedner,et al.  Inter- and Intra-Assay Reproducibility of Microplate Alamar Blue Assay Results for Isoniazid, Rifampicin, Ethambutol, Streptomycin, Ciprofloxacin, and Capreomycin Drug Susceptibility Testing of Mycobacterium tuberculosis , 2008, Journal of Clinical Microbiology.

[20]  Liem Nguyen,et al.  Protein Kinase G Is Required for Intrinsic Antibiotic Resistance in Mycobacteria , 2009, Antimicrobial Agents and Chemotherapy.

[21]  Ashutosh Kumar,et al.  Knowledge Based Identification of Potent Antitubercular Compounds Using Structure Based Virtual Screening and Structure Interaction Fingerprints. , 2009 .

[22]  Gareth Jones,et al.  A genetic algorithm for flexible molecular overlay and pharmacophore elucidation , 1995, J. Comput. Aided Mol. Des..

[23]  Amita Jain,et al.  Extensively drug-resistant tuberculosis: current challenges and threats. , 2008, FEMS immunology and medical microbiology.

[24]  Carsten Kutzner,et al.  GROMACS 4:  Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. , 2008, Journal of chemical theory and computation.

[25]  Ning Sun,et al.  Identification of a New Class of FtsZ Inhibitors by Structure-Based Design and in Vitro Screening , 2013, J. Chem. Inf. Model..

[26]  Kazuo Kitaura,et al.  Structure-based design of novel potent protein kinase CK2 (CK2) inhibitors with phenyl-azole scaffolds. , 2012, Journal of medicinal chemistry.

[27]  A. Velayati,et al.  Totally drug-resistant tuberculosis strains: evidence of adaptation at the cellular level , 2009, European Respiratory Journal.

[28]  David S. Goodsell,et al.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..

[29]  Tudor I. Oprea,et al.  WOMBAT: World of Molecular Bioactivity , 2005 .

[30]  S. Smale,et al.  Luciferase assay. , 2010, Cold Spring Harbor protocols.

[31]  Ajay N. Jain.  Surflex: fully automatic flexible molecular docking using a molecular similarity-based search engine. , 2003, Journal of medicinal chemistry.